IM Cannabis (IMCC) Inventory (2019 - 2026)

IM Cannabis (IMCC) posted quarterly Inventory of $1.5 million for Q1 2026, down 52.32% quarter-over-quarter from $3.1 million in Q4 2025.

IM Cannabis (IMCC) Inventory (2019 - 2026) Analysis & Trends

IM Cannabis' Inventory history runs 8 years deep, the most recent figure standing at $1.5 million for Q1 2026.

In Q1 2026, Inventory changed N/A year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $3.1 million, up 30.33% from the prior year.
Inventory for Q1 2026 stood at $1.5 million, down from $3.1 million in the prior quarter.
The five-year high for Inventory was $24.0 million in Q1 2022, with the low at $1.5 million in Q1 2026.
The 5-year median for Inventory is $7.3 million (2023), against an average of $8.6 million.
The sharpest annual moves came in 2022 and 2024: Inventory jumped 168.13% in 2022, then slumped 68.59% in 2024.
IM Cannabis' Inventory stood at $12.2 million in 2022, then sank by 40.03% to $7.3 million in 2023, then sank by 68.59% to $2.3 million in 2024, then soared by 32.98% to $3.1 million in 2025, then slumped by 52.32% to $1.5 million in 2026.
Business Quant data shows IMCC's Inventory at $1.5 million in Q1 2026, $3.1 million in Q4 2025, and $7.3 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	1.44 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	3.22 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	2.57 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	9.08 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	193.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	3.93 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	104.20 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	1.77 Bn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	816.00 Mn
10	IM Cannabis	554,496.00	-614,474.17	1.09 Mn	2.07 Mn

Download Data